FDA Investigator Kellie L Thommes, RN

Kellie L Thommes, RN has inspections in 7 countries as of 11 Oct 2023. Kellie L Thommes, RN has collaborated with a combinined 3074 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
155
Last Inspection Date:
11 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100002779
Country:
United States of America, China, Ukraine, Ireland, Canada, India
Co-Investigator(s):
A Williams, Aaron L Dunbar, Aimee J Edwin, Alan R Albrecht, Alfred P Pistorio, Alison A Nicoli, Alison A Stone, Alla Dubrovsky, Amos, Amy L Mcintyre, Ana M Placencia, Andrea A Branche, Andrea B Slavin, Andrew A Hoopes, Annabelle Crusan, D,VM, Anthony J Ladner, Anthony R Petriella, April L Brown, April L Young, Baask, Barbara Janine Breithaupt, Benjamin W Anderson, Billi Jom Johnson, Brent T Hall, Brian E Thompson, Carl J Montgomery, Carolyn A Warren, Christina A Castineyra, Como, Cordelia J Brammer, Corey K Reno, Courtney R Ingalsbe, Courtney R Tiegs, Dale A Nyberg, Darlene L Krieger, Darren D Holaday, David B Wieneke, Demetria L Lueneburg, Denise L Burosh, Doretha M Tonkins, Doretha M Wilson, Douglas W Atkins, Dustin R Abaonza, Edward A Fabiano, Edward M James, Elizabeth E Hart (ASCP), MT, Elizabeth E Marc, Ellen C Weisensel, Eric S Myskowski, Eric T Huebler, Fannie M Harrell, Francis J Eng, Gary L Zaharek, Gina M Scholze, Grant M Ruis, Gregory S Larson, Gregory W Smith, Harperd, Heather Akleimola Hulbert, Heidi J Debeck, Howard A Burmester, Hugh M Mcclure, II, Hustedtj, Ismael Olvera, IV, Ivan E Reyes, Jake T Lane, James A Beaulieu, James A Lane, Jan L Hewett, Jane E Nelson, Janete F Guardia, Jay V Jariwala, Jennifer Alongie Vollom, Jennifer L Custodio, Jennifer S Ness, Jeremy L Tri, Jesse P Romenesko, Jessica L Johnson, Jessica M Novak, Jocelyn M Muggli, John A Iwen, John E Emmert, Joseph D Gong, Joseph J Golden, Joseph M Edwin, Joseph R Haynes, Julie Woodberry, Karen M Jirele, Karen M Labounty, Karen M Montgomery (KMM), Karla J Youngberg, Kathleen R Jones, PhD, Kellie L Westerbuhr, Kevin P Regan, Kimberly Lewandowski Walker, Kip J Hanks, Krista K Petersen, Kristy E Zuroski, Kyle J Mccracken, Laureen F Kononen, Lauren M Lilly, PhD, Linda Galindo, Linda R Kuchenthal, Linda V Weyer, Lori P Peters, Mada A Tautges, Maida Henesian (NMI), Marcus F Yambot, Margaret L Bolte, Maria E Treadwell, Marie A Fadden, Marissa S Henning, Marissa S Steinhagen, Marla A Cassidy, Mary Ann Ruff, Matthew B Casale, Melissa D Kalik, Melissa I Michurski, Melissa J Holz, Michael T Nehring, Michelle J Glembin, Miles D Foster, Miriam M Ngundi, Mohammed H Adam, Msdap Gonzlezk, Nancy A Bellamy, Nancy L Neiger, Natalie A Mickelsen, DVM, Nicole C Victoria, PhD, Norman Wong, Paola E Lathrop, Patricia A Holmstrom, Ralph Jerndal, Randy L Clarida, Rhonda L Mecl, Rhonda L Meel, Robert H Claflin, Robert J Waldorf, Ronald R Ruff, Ronda R Loyd Jones, Ross J Grigsby, Rostislav Servetnyk, Sana A Elassar, Sandra Sejdinovic, Sarah A Palmer, Scott A Golladay, Scott B Laufenberg, Shanna R Haden, Sharon K Thoma, PharmD, Sharon L Matson, Sharon M Harold, Shaun M Olson, Sonya L Karsik, Soyinka S Eneng, Srinivas R Chennamaneni, PhD, State Agency, Susan A Atcher, Susan M Atcher, Susan M Matthias, Susan M Miller, Susan M North, Tara C Singh, Theresa C Klaman, Timothy G Philips, Timothy R Marrs, Tony T Yang, Traci C Kelm, Traci M Armand, Travis S Bradley, Troy A Brenny, Wayne W Grundstrom, William D Tingley, William E Keer, Yehualashet A Gessesse, Zachary P Wachlarowicz

Kellie L Thommes, RN's Documents

Publish Date Document Type Title
February, 2019 FDA 483 Leslie Forgosh - Form 483, 2019-02-27
October, 2015 EIR Angela R. Smith, M.D., M.S. - EIR, 2015-10-28
September, 2021 FDA 483 Mark R. Newton, M.D. - Form 483, 2021-09-23
April, 2018 EIR American Preclinical Services - EIR, 2018-04-13
July, 2015 EIR Affinity Health System, Inc. (IRB) - EIR, 2015-07-08
August, 2018 FDA 483 Human Subjects Research Committee - Form 483, 2018-08-23
September, 2013 FDA 483 Steris Laboratories - Form 483, 2013-09-13
August, 2018 FDA 483 Response Human Subjects Research Committee - Form 483R, 2018-09-14
July, 2015 FDA 483 Response Affinity Health System, Inc. (IRB) - Form 483R, 2015-07-30
September, 2016 FDA 483 Entellus Medical - Form 483, 2016-09-27
February, 2020 FDA 483 Scott Okuno, M.D. - Form 483, 2020-02-28
July, 2013 FDA 483 University of Minnesota Medical Center, Fairview - Form 483, 2013-07-30
January, 2023 FDA 483 Kathleen Jones, M.D., Clinical Investigator - Form 483, 2023-01-13
September, 2015 FDA 483 Jeffery Chambers - Form 483, 2015-09-18
May, 2015 EIR Goddard, Dr James K - EIR, 2015-05-14
September, 2018 FDA 483 HealthEast Institutional Review Board - Form 483, 2018-09-13
February, 2019 FDA 483 3M Company - Health Care Business - Form 483, 2019-02-11
September, 2016 FDA 483 Response Entellus Medical - Form 483R, 2016-10-12
April, 2018 FDA 483 American Preclinical Services - Form 483, 2018-05-01
November, 2021 FDA 483 Northern Biomedical Research, Inc. - Form 483, 2021-11-13
June, 2021 FDA 483 Robert McBane, M.D. - Form 483, 2021-06-23
July, 2015 FDA 483 Affinity Health System, Inc. (IRB) - Form 483, 2015-07-08
April, 2019 FDA 483 Jon B. Cole, MD - Form 483, 2019-04-26
January, 2018 FDA 483 Colin L. Driscoll, M.D. - Form 483, 2018-01-17
June, 2018 EIR Upsher-Smith Laboratories, LLC - EIR, 2018-06-21
February, 2019 FDA 483 Response 3M Company - Health Care Business - Form 483R, 2019-02-27
July, 2016 FDA 483 Peter Karachunski, M.D. - Form 483, 2016-07-16
February, 2022 FDA 483 Centracare St. Cloud Hospital - Irb - Form 483, 2022-02-18
July, 2013 EIR University of Minnesota Medical Center, Fairview - EIR, 2013-07-30
July, 2018 FDA 483 Kyung-Hun Lee - Form 483, 2018-07-20
February, 2019 EIR 3M Company - Health Care Business - EIR, 2019-02-11
October, 2015 FDA 483 Angela R. Smith, M.D., M.S. - Form 483, 2015-10-28
March, 2019 FDA 483 Paul Sorajja, M.D., Clinical Investigator - Form 483, 2019-03-22
September, 2021 EIR Mark R. Newton, M.D. - EIR, 2021-10-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more